- Presentations
- 2
- Markets
- 1
Xenleta is a brand of Lefamulin marketed by Meitheal Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lefamulin
- Brand owner
- Meitheal Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 150 mg/15 mL injection, 600 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Xenleta 150 mg/15 mL injectionIntravenous Cold chain | Meitheal Pharmaceuticals | US FDA | Available on request |
| Xenleta 600 mg tabletOral Cold chain | Meitheal Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Xenleta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.